Trial results and drug combinations for bortezomib in multiple myeloma
Clinical management of venetoclax in multiple myeloma
The important issues to consider when deciding when a multiple myeloma patient must start treatment
The clinical implications of progenitor cells in multiple myeloma
Gareth Morgan et al.
What’s new in minimal residual disease (MRD) detection in myeloma?